+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Market Spotlight: Chemotherapy-Induced Anemia - Product Thumbnail Image

Market Spotlight: Chemotherapy-Induced Anemia

  • Report
  • February 2021
  • 32 Pages
  • Global
Market Spotlight: Myelodysplastic Syndrome (MDS) - Product Thumbnail Image

Market Spotlight: Myelodysplastic Syndrome (MDS)

  • Report
  • February 2021
  • 60 Pages
  • Global
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Vaginal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Vaginal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 475 Pages
  • Global
From
Market Spotlight: Small-Cell Lung Cancer (SCLC) - Product Thumbnail Image

Market Spotlight: Small-Cell Lung Cancer (SCLC)

  • Report
  • November 2020
  • 49 Pages
  • Global
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Head And Neck Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 3419 Pages
  • Global
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Protein Kinase C Theta Type - Pipeline Review, H2 2020 - Product Thumbnail Image

Protein Kinase C Theta Type - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 33 Pages
  • Global
From
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020 - Product Thumbnail Image

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 152 Pages
  • Global
From
Myelodysplastic Syndrome - Pipeline Review, H1 2020 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1667 Pages
  • Global
From
Histone Lysine N Methyltransferase EZH2 - Pipeline Review, H1 2020 - Product Thumbnail Image

Histone Lysine N Methyltransferase EZH2 - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 96 Pages
  • Global
From
From
From
Investigation Report on China's Pegaspargase Market, 2019-2023 - Product Thumbnail Image

Investigation Report on China's Pegaspargase Market, 2019-2023

  • Report
  • September 2019
  • 30 Pages
  • China
From
Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019 - Product Thumbnail Image

Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019

  • Report
  • September 2019
  • 29 Pages
  • Global
Inlyta (axitinib; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Inlyta (axitinib; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 20 Pages
  • Global
Sutent (sunitinib; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Sutent (sunitinib; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 19 Pages
  • Global
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more